Program ACTIVE II: Design and Methods for a Multi-Center Community-Based Depression Treatment for Rural and Urban Adults with Type 2 Diabetes by de Grogg, Mary et al.
Program ACTIVE II: Design and Methods for a Multi-Center 
Community-Based Depression Treatment for Rural and Urban 
Adults with Type 2 Diabetes
Mary de Groot1,*, Jay Shubrook2, Frank Schwartz3, W. Guyton Hornsby Jr4, Yegan Pillay5, 
and Chandan Saha1
1Indiana University School of Medicine, USA
2Touro University School of Medicine, USA
3Ohio University Heritage College of Osteopathic Medicine, USA
4West Virginia University School of Medicine, USA
5Ohio University, USA
Abstract
Objective—Depression affects one in four adults with type 2 diabetes (T2DM) and is associated 
with worsened diabetes complications, increased health care costs and early mortality. Rural and 
low-income urban areas, including the Appalachian region, represent an epicenter of the T2DM 
epidemic. Program ACTIVE II is a comparative effectiveness treatment trial designed to test 
whether a combination of cognitive behavioral therapy (CBT) and community-based exercise 
(EXER) will offer greater improvements in diabetes and depression outcomes compared to 
individual treatment approaches and usual care (UC). The secondary aims are to assess changes in 
cardiovascular risk factors across groups and to conduct a cost-effectiveness analysis of predicted 
incidence of cardiovascular complications across groups.
Methods—The study is a 2-by-2 factorial randomized controlled trial consisting of 4 treatment 
groups: CBT alone, EXER alone, combination of CBT and EXER, and UC. Adults with T2DM 
for > 1 year and who meet DSM-IVTR criteria for Major Depressive Disorder (MDD) are eligible 
to participate at two rural Appalachian sites (southeastern Ohio and West Virginia) and one urban 
site (Indianapolis). This type II behavioral translation study uses a community-engaged research 
(CEnR) approach by incorporating community fitness centers and mental health practices as 
interventionists.
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Conclusions—This is the first study to evaluate the comparative effectiveness of combined CBT 
and exercise in the treatment of depression using community-based intervention delivery. This 
approach may serve as a national model for expanding depression treatment for patients with 
T2DM.
Introduction
Nearly one in 10 Americans has diabetes and current projections estimate diabetes will 
affect one in three Americans born in the year 2000 [1] resulting in annual T2DM-related 
costs of $256 billion [2]. Low-income urban and rural areas such as the Appalachian region 
bear a disproportionate burden of the national T2DM epidemic [3]. In West Virginia (WV), 
the statewide age-adjustment prevalence of diagnosed T2DM is 10.4% [4] while the average 
prevalence rate of T2DM in rural Appalachian Ohio (OH) counties is 11.3% [5] exceeding 
the national average of 9.3% [1].The Appalachian region also bears a disproportionate 
burden of major depressive disorder (MDD; 8.2%) compared to non-Appalachian areas 
(7.6%), with higher rates found in central Appalachian states (10.6%) such as WV and OH 
than northern or southern states [6].
Barriers to care for T2DM and MDD in low-income urban and rural areas such as central 
Appalachia are considerable and similar. Decreased access to health and mental health care 
providers, lack of public transportation and rising costs for private transportation (e.g. gas 
prices) in the context of geographic isolation pose significant barriers to consistent and 
effective health and mental health care [7–8]. Patients with T2DM have been found to be 
two times more likely to experience depressive symptoms than their non-diabetic peers with 
one in four patients reporting clinically significant depressive symptoms and 11.4% meeting 
criteria for MDD [9].
Depressive symptoms have been shown to be associated with worsened blood glucose levels 
[10] and T2DM complications [11]. In addition, significant functional and financial costs are 
associated with depression and T2DM including decreased adherence to diabetes care 
regimens[12], increased functional disability [13], increased health care costs without 
resulting improvements in depression or diabetes outcomes [14], decreased quality of life 
[15–16]and earlier mortality attributable to all causes (17–18).
Few controlled treatment trials have been conducted to treat depression and T2DM [19–23]. 
Only three have evaluated behavioral treatment strategies in this population. In a meta-
analysis of 29 randomized controlled trials evaluating cognitive behavioral therapy (CBT) 
treatment for MDD across a continuum of disease states, a robust effect size (−.83) 
documented the efficacy of this approach [24]. In a study of 51 patients 
(meanage53+10years;60%female)diagnosedwithT2DM(meanduration 8 years) and MDD 
randomly assigned to a 10-week individualized CBT or control condition without 
medication intervention, Lustman found that patients receiving CBT were 3 times more 
likely to experience depression remission at post-treatment assessment than controls [19]. 
Although no group differences in A1c levels were found at post-treatment assessment 
(adjusted for baseline values), patients in the CBT condition showed improvement in A1c at 
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the 6-month follow-up assessment compared to controls [19]. Treatment responsiveness 
appeared to be associated with severity of depression and A1c at baseline [19,25].
In the Pathways Study, problem-solving therapy (a variation of CBT) was integrated within 
the primary care setting to treat depression in adults with T2DM [23]. Participants 
randomized to a stepped-care problem-solving therapy intervention reported higher levels of 
treatment exposure, satisfaction with care and improved depression outcomes compared to 
patients in the usual care group. In this study, improvements in glycemic control were not 
observed immediately following care or at 6- or 12-month follow-up assessments [23].Taken 
together; these studies demonstrate the efficacy of CBT in treating depression in adults with 
T2DMwith mixed results associated with changes in glycemic control.
Exercise has the potential to directly improve glycemic outcomes in the context of MDD 
treatment and has been shown to be an efficacious treatment for clinical depression among 
adults without T2DM [26–27]. In a meta-analysis of 37 exercise intervention trials in 
clinically depressed samples, Craft & Landers [28]found a large overall effect size (−.72) in 
the reduction of clinical depression with the greatest impact found in samples with 
moderate-to-severe levels of depression. Exercise interventions of 9 to12 weeks showed 
significantly greater impact on depression outcomes, but no differences were observed in the 
types of exercise used in treatment protocols. Exercise interventions have also been shown to 
improve glycemic control in patients with T2DM [29–34].
To date, only one randomized controlled trial (RCT) has examined the impact of exercise on 
depression in adults with type 2 diabetes. Piette and colleagues randomized 291 adult 
patients with T2DM and depressive symptoms (mild to severe) to 12 weeks of manualized 
telephone-based CBT (with 9 monthly booster sessions) with a walking programor enhanced 
UC [35]. At 12-month follow-up, 58% of participants in the intervention group had 
depressive symptoms fall below the mild threshold. Number of steps was higher and systolic 
blood pressure was lower in the intervention group at follow-up. No changes were observed 
in A1c at the 12-month follow-up assessment [35]. The telephone-based CBT and walking 
interventions were combined and could not be evaluated for depression and A1c outcomes 
separately.
To date, the existing literature has utilized traditional randomized controlled trials that make 
use of research or health care personnel to implement the interventions. No studies have 
evaluated the comparative effectiveness of CBT and exercise by implementing these 
interventions with community fitness and mental health providers using a community-
engaged research (CEnR) approach. The challenge for health care providers and 
communities is to create depression treatment programs for T2DM patients that will reach 
the largest number of people at the lowest possible cost and burden to health care 
organizations. Program ACTIVE II has been designed to create a model program of 
community-based depression treatment using a CEnR design that may be disseminated and 
adopted nationally. Central to this model is the assumption that effective depression 
treatment requires multiple avenues of access beyond the formal health care system and 
multiple approaches to depression treatment such as CBT and exercise. Program ACTIVE II 
has been designed to simultaneously achieve two overarching goals: 1) to test the 
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comparative effectiveness of the cognitive behavioral therapy (CBT) and community-based 
exercise (EXER) to usual care (UC); and 2) to develop a sustainable program that may be 
used as a scalable model for T2DM and depression treatment for national dissemination. 
The research team has partnered with community mental health providers and exercise 
facilities to implement the intervention. This paper reports on the innovative design and 
methodology of this large-scale multi-site trial.
Research Design and Methods
Program ACTIVE II is a 2-by-2 factorial repeated measures RCT design. The study is a 
multi-center trial in 3 states designed to maximize generalizability of the findings across 
high risk groups in both urban and rural areas to assess outcomes and to build the 
infrastructure necessary to achieve a sustainable program. Program ACTIVE II uses a 
community-engaged research (CEnR) approach in which community organizations are 
engaged in all aspects of the study: recruitment, intervention implementation, and 
dissemination of findings. This approach confers additional validity to the study outcomes 
by examining the effectiveness of the intervention in the sites where they are ultimately 
designed to take place and demonstrated stakeholder commitment to the intervention which 
serves as a foundation for the ultimate adoption of the Program ACTIVE intervention 
beyond the period of federal funding.
The purpose of Program ACTIVE II is to address two primary aims: 1) to compare changes 
in glycemic control across individual intervention groups to usual care (UC) at post-
intervention (POST) and 6- and 12-month follow-up assessments; and 2) to compare 
changes in MDD outcomes across individual intervention groups to UCat POST and 6- and 
12-month follow-up assessments. The study will also address two secondary aims: 1) to 
compare changes in cardiovascular risk factors (e.g. LDL cholesterol) across individual 
groups to UC at each of the 3 time points; and 2) to calculate the cost-effectiveness of each 
treatment arm in terms of predicted incidence of cardiovascular complications over a 10-year 
period.
Sample size
Based on our pilot study [36] and a meta-analysis by Boule et al., we used a conservative 
assumption of a mean (SD) difference of 0.6% (1.4%) in improving A1c between the UC 
and exercise groups at post intervention [29].Using a sample size of 43 in each of the four 
treatment groups will have 80% power to detect the main effect of exercise. However, we 
will recruit 54 per group assuming a 20% dropout rate.
In estimating the sample size to detect changes in MDD outcomes, we assumed 60% and 
30% remission rates for the CBT and UC groups, respectively, at post intervention [19]. 
Using a sample size of 43 in each of the four treatment groups will have 97% power to 
detect the main effect of CBT.
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Randomization
A site-specific computer generated randomization list was used to randomly assign study 
subjects to one of the four treatment groups. A block size of four was used to ensure balance 
in number of subjects recruited in four groups after recruiting every four subjects.
Characteristics
Inclusion/Exclusion Criteria—Inclusion criteria: age 18 or older, ambulatory status, 
diagnosis of T2DM for one year duration or longer, major depression lasting 2 weeks or 
longer with no evidence of psychotic symptoms. Medical exclusion criteria include: history 
of diabetic ketoacidosis (DKA), continuous insulin therapy since T2DM diagnosis, stage 2 
hypertension as defined by JNC VII, recent cardiac events (e.g. unstable angina, diagnosed 
angina, PTCA, any cardiac intervention for CAD or tachydysrhythmias in the past 6 
months), laser surgery for proliferative retinopathy in the past 6 months, history of stroke, 
lower limb amputation, asensory peripheral neuropathy, aortic stenosis or other severe 
valvular heart disease, atrial fibrillation, severe COPD (e.g., basal oxygen), class III or IV 
heart failure or medical instability. Psychiatric exclusion criteria include: active suicidal 
ideation or a history of suicide attempt, bipolar depression or history of psychotic disorder 
and current substance abuse or dependence disorder. Participants who are currently 
prescribed antidepressant medications for 6 weeks or longer and who meet diagnostic 
criteria for major depression without psychotic features are included.
Participants who report the use of a current antidepressant medication for 5 weeks or less are 
excluded or deferred for later screening after the 6-week period. Participants who are 
currently receiving psychotherapy from a mental health provider for MDD are excluded. 
Participants who are currently receiving only medication management from a psychiatrist 
are included. Respondents who meet eligibility criteria are invited to participate in the 
baseline screening assessment and referred to their local site PI.
Recruitment
Participants are recruited from communities served by the 3 intervention areas: Indianapolis, 
southeastern Ohio/western West Virginia and north central West Virginia. Advertising takes 
place via physician offices, newspapers, radio stations, community centers, partnering 
community organizations and community events. In addition, patients of partner medical 
practices are contacted by phone to receive information about the study and to inquire about 
interest and eligibility (IU and WV). The recruitment flow chart is shown in Figure 1 
(below).Individuals are screened by telephone by trained study staff to determine initial 
eligibility. Once eligible via phone screen, participants are scheduled for a baseline 
assessment visit where the informed consent takes place. Medical and psychiatric data from 
the baseline assessment are reviewed by the study or site medical directors (JS. FS, KF, 
KM), exercise physiologist (GH) and PI (MdG) as a group to determine eligibility for study 
enrollment. Eligible participants are then randomly assigned to one of the four groups: CBT, 
EXER, CBT+EXER or UC.
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Assessment procedures
Psychological, behavioral and physiologic measures are administered at each assessment 
period: baseline, post-intervention, 6- and 12-month follow-up with the exception of 
demographic characteristics (baseline only). Measures are shown in Table 1.
At the beginning of the baseline assessment visit, individuals are consented to participate in 
the study by the Site PI or project coordinator. Baseline assessment includes the medical 
history interview, blood draws, anthropometric measurements and fitness assessment. 
Participants are given a pedometer, food and activity diaries and questionnaires to complete 
following the baseline assessment. Participants complete psychosocial measures at home 
(returned by mail) and complete a SCID Axis I interview by phone. The core investigator 
team, site PIs and project coordinators conduct weekly teleconferences to review all data 
following baseline assessment. Participants who meet all study criteria are randomized to 
one of the four intervention groups, scheduled for a free nutritional education program and 
their first intervention session (CBT, EXER or CBT+EXER) the following week.
Interventions
The active interventions in Program ACTIVE II are 12-weeks of community-based exercise 
and 10 individual sessions of CBT. In order to facilitate diabetes education and to offer an 
incentive to UC participants, Dining with Diabetes nutrition classes are provided to 
participants in all arms. Based on prior studies, nutrition education is not expected to 
influence depression outcomes [19].
CBT Intervention—CBT has gained wide acceptance as an efficacious intervention 
approach for the treatment of depression [50]. CBT posits that cognitions, emotions and 
behaviors are interwoven and mutually reinforcing in the depressed patient [50]. Treatment 
involves the identification and reframing of “automatic thoughts” (i.e., cognitive biases) that 
work in the service of depressogenic core cognitive beliefs [50]. Cognitive biases and core 
beliefs are empirically tested and restructured. Behavioral techniques, such as increasing 
daily activity and development and interaction with social support networks are interwoven 
into CBT therapy [50]. The use of cognitive and behavioral tools modeled in therapy and 
generalized by the participant through take home activities provides participants with an 
opportunity to generalize skills to situations beyond the therapeutic relationship.
CBT sessions are conducted by trained licensed mental health providers currently in practice 
in their respective communities. They represent the range of practice environments from 
individual private practitioners to community mental health centers. Participants receive 10 
sessions of CBT using the manualized approach based on Beck’s model of cognitive therapy 
[50].Sessions are scheduled weekly over the course of the 12-week period. In light of the 
large array of skills that are possible to include in the CBT framework, selected goals have 
been targeted for our brief therapy format (presentation of CBT model; thought records, 
cognitive distortions, counterarguments, cognitive reframing, automatic thoughts, core 
beliefs, and relapse prevention). CBT therapists receive training in CBT and manualized 
training approach from the study team.
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Exercise Intervention—The exercise protocol is a community-based exercise 
intervention based on the aerobic exercise goals adapted from the Lifestyle Balance behavior 
arm of the DPP [44]. Partner exercise facilities represent a range of fitness facilities 
including physical therapy practices, community centers and for-profit and non-profit fitness 
organizations (e.g. YMCA). Trained instructors at each facility provide 6 classes of 
monitored instruction on exercise to participants to meet heart rate and activity-level goals. 
Membership to the centers is provided to participants free of cost throughout the 12-week 
intervention period. Passes to fitness facilities and costs for time spent with the fitness 
trainer are purchased by the grant to increase access to exercise for the duration of the 
protocol. These costs replicate costs of the program to community members of an 
independent program.
Exercise goals are adapted to accommodate the physical and medical restrictions of an 
older-adult T2DM population. Exercise prescriptions are based on the results obtained from 
the baseline 6MWT. Participants are given exercise goals of performing 150 minutes per 
week of moderate activity at 40- <60% of heart rate reserve (HRR), comparable to a Rating 
of Perceived Exertion of 11–13. These goals may be modified based on results of the 6 
Minute Walk Test (6MWT). Due to high rates of sedentary behaviors in this population, 
physical activity goals are increased in a graduated fashion during Weeks 1–3, beginning 
with 100 minutes of weekly aerobic exercise to 150 minutes of total aerobic weekly exercise 
by Weeks 4–12 [47]. Intensity of activity begins at 40% in Week 1 and progresses as 
tolerated, but continues to remain below 60% of HRR.
In order to provide participants with the necessary training to begin a safe exercise program, 
exercise classes are taught by trained fitness instructors at each exercise site in Weeks 1–4 
and again in Weeks 6 and 8. In Week 1, participants are introduced to the proper use of 
exercise equipment and the exercise prescriptions. During these sessions, participants are 
monitored for 50-minutes of exercise by the exercise fitness instructor. Participants are 
trained to exercise in a manner consistent with ACSM recommendations including 10 
minutes of pre-activity (warm-up and stretching), 30 minutes of active exercise (endurance), 
and 10 minutes of post-activity (cool down, recovery) [47,51]. Participants receive feedback 
throughout the 50-minute session on their intensity for each given activity. Heart rate and 
blood pressure are measured at rest, at peak activity level, and following recovery. 
Participants are trained to utilize the Borg Scale [52] during their activity to monitor exercise 
intensity.
In Weeks 2–4, participants are given personalized instruction on exercise modes available 
including walking on a track, use of treadmills and stationary recumbent/upright ergometers 
consistent with the equipment of each fitness location. In weeks 6 and 8, participants attend 
an in-person booster session at their local exercise center to re-establish the appropriate 
exercise intensity and assess exercise technique. Exercise prescriptions may be adjusted at 
this time based on the information obtained about exercise intensity. At each class, a chapter 
from the Program ACTIVE II Exercise Manual is provided to participants. Adapted from the 
DPP Lifestyle Balance intervention materials, the manual is designed to address 
psychological barriers associated with physical activity (e.g. social support, motivation, 
behavioral goals).
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Participants are asked to complete weekly exercise diaries and to record number of steps 
measured using pedometers provided by the study (Weeks 1–12) on paper or in electronic 
form through the website. Participants are contacted bi-weekly by a member of the study 
team to review information from activity diaries and pedometers and to evaluate any 
exercise-related medical concerns including: hyperglycemia, hypoglycemia, joint pain, back 
pain, angina, lightheadedness, and symptoms of hypotension. Data from participants who 
report medical symptoms resulting from exercise will be shared with the Medical Director 
for the respective site. The development of severe adverse events is communicated to the site 
Medical Director, Data Safety and Monitoring Panel and hosting IRB offices for 
consultation. SMBG data is downloaded electronically to examine significant changes in 
daily blood sugars as a result of exercise. Participants who show increased instances of 
hyper- or hypoglycemia are contacted by the project coordinator and advised to contact their 
primary care provider for assessment of medications. Participants are provided with 
electronic (via website) and paper (as needed) supplemental adherence materials (i.e. toolkit) 
such as walking maps, self-care information, and games to promote adherence.
Nutrition Intervention—In order to evaluate the effectiveness of the target interventions 
in the context of T2DM treatment best practices, participants in all 4 groups are provided 
classes in the Dining with Diabetes (DWD) program through The Ohio State University, 
West Virginia University Extension or Purdue University Marion County Extension.
Statistical analyses
The intention-to-treat principle will be used for all analyses. Differences in participants’ 
baseline characteristics among 4 groups will be evaluated by ANOVA or the nonparametric 
Kruskal-Wallis test for continuous outcomes and by Chi-square test for categorical 
outcomes. A mixed-model analysis of variance including site, treatment group, time, gender, 
race, age, baseline value of A1c will be used to assess the effects of exercise on A1c at post-
intervention, 6- and 12-month. Participants will be treated as a random effect and a un-
structure covariance matrix will be used. The dichotomous primary outcome, remission in 
depression, will be analyzed by a non-linear mixed-effects model and will adjust for 
potential confounder’s gender, race, age and baseline depression score. In each of the above 
two models, an interaction effect between time and treatment group will be assessed first. If 
there is no interaction effect, the overall treatment difference will be assessed. Otherwise, 
treatment difference will be assessed at each time point. The model will be fitted by the SAS 
procedure NLMIXED.
Secondary Outcomes
Functional exercise status and cardiovascular risk factors
A repeated measures ANCOVA will be conducted to assess changes in highest HR during 
the 6 minute walk test, distance achieved, LDL-C, HDL-C, triglycerides, and resting blood 
pressure from baseline to POST and baseline to the 6- and 12-month assessments.
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Cost-effectiveness (CE) analyses
A Markov decision model of type 2 diabetes progression to complications will be 
constructed using cost data collected at baseline, post-intervention, 6 and 12 months of 
follow-up. Short- and long-term effects of the intervention can be estimated by including 
time horizons 3, 10, 20 and lifetime in the Markov model. All costs will be adjusted to the 
year 2007 using the US Consumer Price Index.
Markov models
We will develop a Markov decision model with sensitivity analyses to estimate the 
Incremental Cost-Effectiveness ratio (ICER) of the intervention compared to UC as 
implemented in Program ACTIVE II. An ICER is computed by the ratio of ΔC/ΔE where 
ΔC represents the change in cost due to the intervention compared with UC and ΔE 
represents the change in health benefits due to the intervention compared with UC. We will 
use TreeAge Pro Suite 2009 software (TreeAge Software, Williamstown, MA). The model 
will directly incorporate intervention effectiveness and cost data as well as event 
probabilities from the RCT to estimate life expectancy, quality-adjusted life-expectancy 
(expressed as QALYs), clinical outcomes (diabetes complications), and direct medical and 
nonmedical costs associated with the interventions and UC.
Data Safety and Monitoring Panel
A Data Safety and Monitoring Panel (DSMP) were created to provide expert consultation in 
the primary disciplines involved in the content of the study: psychology, medicine, and 
exercise physiology. These consultants provide input on issues such as metabolic or 
physiological changes in participants during participation, mental status of participants, and 
implementation of the exercise protocol throughout Program ACTIVE II. Members of the 
panel are available for consultation for issues of research ethics, clinical care, and human 
subject’s protection. Members of the panel are independent from the research team to ensure 
objectivity in the treatment of participants.
Data integrity is reviewed by the Core Investigators in consultation with Dr. Chandan Saha 
of the IUSM Department of Biostatistics. The Core Investigators meet monthly by phone to 
discuss issues related to recruitment, implementation of the intervention, participant safety, 
and to monitor data trends (e.g., adherence, missing data.
Conclusions
T2DM and co-morbid depression represents a growing challenge to patients and health care 
systems as the prevalence of both disorders rises but access to treatment remains limited. In 
this study, we are investigating the comparative effectiveness of a combination of CBT and 
exercise using a CErN approach in which community fitness and mental health partners 
provide depression treatment to study participants. This approach is novel because it is the 
first study to examine the comparative effectiveness of two behavioral treatment approaches 
to depression and T2DM. Moreover, it leverages community resources such as fitness 
centers, community centers and community mental health professionals that already exist in 
rural and low-income urban communities to serve as treatment partners to health care 
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centers. At the same time, it expands knowledge of diabetes treatment issues to these 
community providers thereby expanding continuity of care for participants.
Data from this study will provide the empirical foundation for community stakeholders to 
evaluate the value of this program in terms of health and mental health outcomes in their 
communities and to identify the ways that this may become a sustainable treatment resource 
for communities beyond the period of federal funding. Lessons learned from this study will 
also inform the dissemination of this intervention as a model that may be scaled to the 
national level to alleviate the burden and costs with this important set of disorders.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Recruitment Flow Chart
Separate randomization lists were generated by the study statistician for use by each study 
site.
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